Computer Assisted Instrument Guidance (CAIG) for Orthopedic Peripheral Nerve Blocks
- Conditions
- Peripheral Nerve Blocks
- Interventions
- Device: Peripheral Nerve Blocks with CAIG
- Registration Number
- NCT02614222
- Lead Sponsor
- Clear Guide Medical
- Brief Summary
The objective of this research is to determine if the addition of the Clear Guide ONE, a Computer Assisted Instrument Guidance (CAIG) system, provides improvement over existing ultrasound guided, needle-based procedures for peripheral nerve blocks. The ultrasound can visualize the targeted vessel or nerve, but the addition of the CAIG may help the clinician better guide the needle to the target.
- Detailed Description
This pilot study will be a randomized, single-blinded control trial. The clinicians cannot be blinded, but the person questioning the patient post-op to determine success rate will be blinded. There will be two randomized groups of patients: control and test. The control group will receive the procedure with traditional methods and equipment currently in use at Cooper University. The test group will receive the same procedure utilizing existing ultrasound equipment with the supplemental CAIG system.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 27
- Undergoing orthopedic surgery who are candidates for peripheral nerve blocks for control of postoperative pain
- Able to give written informed consent
- Unable to give informed consent
- Patients in whom regional anesthesia is contradicted
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Peripheral Nerve Block with CAIG Peripheral Nerve Blocks with CAIG The participants in this group (test group) will utilize the same procedure utilizing existing ultrasound equipment with the supplemental CAIG system.
- Primary Outcome Measures
Name Time Method Time Needed to Correctly Identify the Neural Structure(s) and Induce the Peripheral Nerve Block Immediately after intervention (within 2 hours)
- Secondary Outcome Measures
Name Time Method Clinician Rating of the Device Immediately following intervention (within 2 hours) Clinician rates the device on a scale of 1-10. This also includes a questionnaire.
Number of Times Needle Needs Repositioning Immediately following intervention (within 2 hours) Number of Patients That Needed Rescue Opioids During hospital stay (maximum 3 days) Number of Attempts Immediately following intervention (within 2 hours) Number of instrument pricks before target is reached
Patient Satisfaction Recorded on Post-op Day 1 Using Questionnaire Post-op day 1 Patient satisfaction will be recorded in the hospital or via phone on post-op day 1, on a 10-point scale (10 being most satisfied), using a questionnaire.
Incidence of Postoperative Nausea and Vomiting During hospital stay (maximum 3 days) Number of participants that reported postoperative nausea and vomiting
Undesired Muscle Weakness Measured Subjectively During hospital stay (maximum 3 days) Number of participants that report undesired muscle weakness. Undesired muscle weakness will be measured subjectively - whether patient unable to ambulate and/or requiring the use of an immobilizer.
Trial Locations
- Locations (1)
The Cooper Health System
🇺🇸Camden, New Jersey, United States